Evaluation of the Blood Lead Screening Component of the Southern Nevada Childhood Lead Poisoning Prevention Program.


Journal

Journal of public health management and practice : JPHMP
ISSN: 1550-5022
Titre abrégé: J Public Health Manag Pract
Pays: United States
ID NLM: 9505213

Informations de publication

Date de publication:
Historique:
entrez: 4 12 2018
pubmed: 7 12 2018
medline: 29 7 2020
Statut: ppublish

Résumé

While public health programs and policies have worked to reduce lead exposure, lead poisoning remains a major preventable public health concern in the United States. In Clark County, Nevada, blood lead level (BLL) screening has historically been sparse. Thus, the purpose of this study was to evaluate the impact of the Southern Nevada Childhood Lead Poisoning & Prevention Program (CLPPP) in increasing screening efforts and identifying children with elevated blood lead levels (EBLLs). The proportion of children screened after the implementation of the CLPPP and the number of children identified with detectable BLLs. A total of 43 028 BLL results for children younger than 6 years were assessed from 2006 to 2011. More than 19% of children tested during the project period had a detectable BLL. The number of BLL tests for children younger than 6 years increased from 4180 in 2005-2006 to 9304 in just the second year of CLPPP implementation. Once the initial implementation grant was over and additional funding was unavailable, the BLL screening once again declined to 5541 in 2016-2017. Evaluation of CLPPP activities suggests that outreach and education efforts, funded by the Centers for Disease Control and Prevention, played a significant role in increasing blood lead screening in Southern Nevada. However, despite these efforts, less than 5% of all children younger than 6 years were screened, which has declined further after the end of federal support.

Identifiants

pubmed: 30507768
doi: 10.1097/PHH.0000000000000882
pii: 00124784-201901001-00007
doi:

Substances chimiques

Lead 2P299V784P

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Pagination

S37-S43

Subventions

Organisme : NCEH CDC HHS
ID : H64 EH000145
Pays : United States

Auteurs

Amanda Haboush-Deloye (A)

Nevada Institute for Children's Research and Policy (Drs Haboush-Deloye and Marquez) and School of Community Health Sciences (Ms Marshall and Dr Gerstenberger), University of Nevada, Las Vegas, Las Vegas, Nevada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH